CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling

Normalization panels for the reliable quantification of circulating microRNAs by RT-qPCR

(2015) Maayke G. M. Kok et al.   FASEB JOURNAL

Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma

(2015) Heather Magnan et al.   PEDIATRIC BLOOD & CANCER

Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression

(2014) M. T. Marino et al.   ANNALS OF ONCOLOGY

Exosomes as divine messengers: are they the Hermes of modern molecular oncology?

(2014) C Braicu et al.   CELL DEATH AND DIFFERENTIATION

Identification and Validation of miRNAs as Endogenous Controls for RQ-PCR in Blood Specimens for Breast Cancer Studies

(2014) Ailbhe M. McDermott et al.   PLoS One

Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications

(2014) Ana Teresa Amaral et al.   PLoS One

Regulation of NF-κB by TNF family cytokines

(2014) Matthew S. Hayden et al.   SEMINARS IN IMMUNOLOGY

The Genomic Landscape of Pediatric Ewing Sarcoma

(2014) B. D. Crompton et al.   Cancer Discovery

Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

(2014) F. Tirode et al.   Cancer Discovery

The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation

(2014) Andrew S. Brohl et al.   PLoS Genetics

MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1

(2013) Ronald TK Pang et al.   BMC CANCER

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence

(2012) M. T. Di Martino et al.   CLINICAL CANCER RESEARCH

PPARγ agonists enhance ET-743–induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma

(2012) Elizabeth Charytonowicz et al.   JOURNAL OF CLINICAL INVESTIGATION

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

(2012) Richard B. Womer et al.   JOURNAL OF CLINICAL ONCOLOGY

Identification of Common and Distinctive Mechanisms of Resistance to Different Anti-IGF-IR Agents in Ewing's Sarcoma

(2012) Cecilia Garofalo et al.   MOLECULAR ENDOCRINOLOGY

Acceleration of astrocytic differentiation in neural stem cells surviving X-irradiation

(2012) Ayumi Ozeki et al.   NEUROREPORT

MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor

(2012) G-A Franzetti et al.   ONCOGENE

Molecular Pathogenesis of Ewing Sarcoma: New Therapeutic and Transcriptional Targets

(2011) Stephen L. Lessnick et al.   Annual Review of Pathology-Mechanisms of Disease

Anticancer effects of the p53 activator nutlin-3 in Ewing’s sarcoma cells

(2011) Jürgen Sonnemann et al.   EUROPEAN JOURNAL OF CANCER

Expression of therapeutic targets in Ewing sarcoma family tumors

(2011) Atif A. Ahmed et al.   HUMAN PATHOLOGY

Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma

(2011) Idriss M Bennani-Baiti et al.   JOURNAL OF PATHOLOGY

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy

(2011) Fumihiko Nakatani et al.   JOURNAL OF PATHOLOGY

Blockade of the NFκB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo

(2011) L Nogueira et al.   ONCOGENE

Modeling Initiation of Ewing Sarcoma in Human Neural Crest Cells

(2011) Cornelia von Levetzow et al.   PLoS One

EWS-FLI1 inhibits TNFα-induced NFκB-dependent transcription in Ewing sarcoma cells

(2010) Julie Lagirand-Cantaloube et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Role of NFKB2 on the early myeloid differentiation of CD34+ hematopoietic stem/progenitor cells

(2010) Greice Andreotti De Molfetta et al.   DIFFERENTIATION

CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis

(2010) Anna Rocchi et al.   JOURNAL OF CLINICAL INVESTIGATION

Long-term Survivors of Childhood Ewing Sarcoma: Report From the Childhood Cancer Survivor Study

(2010) J. P. Ginsberg et al.   JNCI-Journal of the National Cancer Institute

Opposing Putative Roles for Canonical and Noncanonical NFκB Signaling on the Survival, Proliferation, and Differentiation Potential of Human Embryonic Stem Cells

(2010) Chunbo Yang et al.   STEM CELLS

Oncogenic Activation of NF- B

(2010) L. M. Staudt   Cold Spring Harbor Perspectives in Biology

TNFα promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-κB signaling pathway

(2009) Katrin Hess et al.   BONE

NF-κB and cancer: how intimate is this relationship

(2009) Sahdeo Prasad et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

EWS-FLI1 Suppresses NOTCH-Activated p53 in Ewing's Sarcoma

(2008) J. Ban et al.   CANCER RESEARCH

EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells

(2008) N. Riggi et al.   CANCER RESEARCH

Shared Principles in NF-κB Signaling

(2008) Matthew S. Hayden et al.   CELL

Inducible Expression of Chimeric EWS/ETS Proteins Confers Ewing's Family Tumor-Like Phenotypes to Human Mesenchymal Progenitor Cells

(2008) Y. Miyagawa et al.   MOLECULAR AND CELLULAR BIOLOGY

RelB is the NF- B subunit downstream of NIK responsible for osteoclast differentiation

(2008) S. Vaira et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA